MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired

Roser Farre Garros1, Richard Paul1,2, Martin Connolly1

  • 11 Molecular Medicine Section and.

Abstract

Insights

Elevated microRNAs (miRNAs), specifically miR-542-3p/5p, contribute to muscle wasting in critical illness by impairing mitochondrial function and activating transforming growth factor-β signaling, leading to muscle atrophy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Skeletal muscle wasting is a significant complication of critical illness and chronic diseases, with unclear underlying mechanisms.
  • Understanding the molecular drivers of muscle loss is crucial for developing effective interventions.

Purpose of the Study:

  • To identify specific microRNAs (miRNAs) elevated in patients experiencing muscle wasting.
  • To elucidate the molecular pathways through which these miRNAs contribute to muscle dysfunction.

Main Methods:

  • Quantification of miRNA-542-3p/5p in quadriceps muscle from patients with chronic obstructive pulmonary disease and intensive care unit-acquired weakness (ICUAW).
  • In vitro and in vivo studies to assess the impact of miR-542-3p/5p on mitochondrial function and transforming growth factor-β signaling.
  • Correlation analysis of miRNA levels with muscle loss in surgical patients.

Main Results:

  • miR-542-3p/5p were significantly elevated in patients with ICUAW and chronic obstructive pulmonary disease.
  • In vitro, miR-542-3p induced mitochondrial ribosomal stress, while miR-542-5p enhanced transforming growth factor-β signaling.
  • In vivo, miR-542 overexpression in mice led to muscle wasting, reduced mitochondrial function, and altered SMAD signaling, mirroring findings in ICUAW patients.
  • Preoperative miR-542-3p/5p levels correlated with postoperative muscle loss in aortic surgery patients.

Conclusions:

  • Elevated miR-542-3p/5p are implicated in muscle atrophy in intensive care unit patients.
  • These miRNAs promote muscle dysfunction by inducing mitochondrial dysfunction and activating SMAD2/3 phosphorylation.